Cite Filings / ALZN
Feed Companies Filings Check
Sign in

CIK 0001677077

  • Emerging growth company

Alzamend Neuro, Inc.

Sign in to watch
Ticker
ALZN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Apr 30
Incorporated
DE
Entity type
Operating
EIN
811822909
Phone
+1 844-722-6333
Business address
480 PEACHTREE ROAD NE, SECOND FLOOR, SUITE 103, ATLANTA, GA, 30326
Filings Financials Insiders Search text
All 400 Financials 95 Shareholder Meetings 12 Executive Compensation 85 Insider Trading 170 Beneficial Ownership Interest 18 Business Combinations 73 Public Offerings 52 Regulation A Offering 25 Mutual Funds and ETFs 6 Others 34
›
Filed in
  1. No filings match these filters. Clear filters
  2. 8-K Event ● Executive or director change 2022-08-05
  3. 8-K Event ▲ Delisting notice 2022-07-18
  4. 8-K Event ▲ Delisting notice 2022-06-28
  5. 8-K Event Regulation FD disclosure 2022-06-06
  6. 8-K/A Event Regulation FD disclosure · Other events 2022-04-20
  7. 8-K Event Regulation FD disclosure 2022-04-18
  8. 8-K Event Regulation FD disclosure 2021-12-17
  9. 8-K Event Regulation FD disclosure 2021-09-30
  10. 8-K Event Regulation FD disclosure 2021-08-17
  11. 8-K Event Regulation FD disclosure 2021-08-04
  12. 8-K Event Regulation FD disclosure 2021-07-28
  13. 8-K Event Regulation FD disclosure 2021-07-23
  14. 8-K Event ● Executive or director change 2021-06-22

Page 4 of 4 · 73 filings

First Previous Next Last

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…